Cost-effectiveness models indicate that a US$1 million investment in anti-tobacco education would save 7000 life years, making smoking cessation roughly ten-times more effective than other preventive therapies. Nevertheless, smoking-cessation therapy is inadequately covered by many USA public and private health insurance plans.
Reasons for opposition to more comprehensive smoking-cessation therapy coverage by public and private payors may include perceived poor return on investment, as insurance beneficiaries switch plans on average every 2-3 years, and greater end-of-life costs when smoking-related mortality is reduced and former smokers live longer than they otherwise might.
Although smoking cessation is clearly beneficial in the long run, little has been published about the short-term economic and clinical effects of a successful cessation attempt. Better data on the cost-effectiveness of smoking cessation could improve coverage and access to smoking cessation interventions.
Existing economic models of the short-term effects of smoking cessation have a few shortcomings, most notably a lack of good data on the short-term effects of smoking cessation on absenteeism and workplace productivity. In addition, existing studies have frequently been too short to see clear benefits.
A short-term focus may lead to suboptimal investment in smoking cessation in the USA from a broader societal view. The policy and social welfare implications of focusing on the short term need to be carefully considered, given that smoking cessation is clearly cost effective in the long run.
The authors gratefully acknowledge Mika K Green and Christine Nichols, research assistants at Boston Health Economics, for assistance with the literature search and manuscript preparation.Funding information
Funding for this study was provided by Pfizer Inc.
Joseph MenzinBoston Health Economics, Inc., 20 Fox Road, Waltham, MA 02451; E-mail: email@example.com.
Expert Rev Pharmacoeconomics Outcomes Res. 2009;9(3):257-264. © 2009 Expert Reviews Ltd.
Cite this: Estimating the Short-term Clinical and Economic Benefits of Smoking Cessation: Do We Have it Right? - Medscape - Jun 01, 2009.